• Building #1, Medical Device Technology Industrial Park, Fuchunjiang Road #188, Suzhou, China.

Over a decade of technology accumulation

PUHENG has accumulated thousands of experimental data to provide you with reliable products and services.

World's first NAC-organ 3D cell culture technology

Drug development platform based on in vitro 3D physiological/pathologicalmodel

Committed to becoming a globally leading provider of in vitro drug developme

We are committed to achieving this goal

About us

Puheng Technology Co., Ltd.

Puheng Technology Co., Ltd (PUHENG) is an innovative company based in Suzhou that specializes in the development of in vitro 3D physiological/pathological models. The team at Puheng possesses extensive experience in biomedical sciences, materials science, and artificial intelligence (AI) technology research and development. The NAC-Organ technology, developed by Puhengusing synthetic biology techniques, is a novel in vitro 3D cultivation technology. It enables standardized and high-throughput production of complex in vitro 3D models.

Puheng Technology focuses on drug in vitro assessment technologies and is dedicated to developing drug development systems based on humanized in vitro 3D models. Leveraging the advantages of NAC-Organ technology, we are specialized in...

  • Development of in vitro 3D complex disease models

  • Drug screening based on in vitro 3D models

  • Development of Regenerative medicine technology

more

Leading technological innovation and industrial transformation

  • NAC-linker is a Cell junction material developed by PUHENG Technology based on Synthetic biology technology.It enables efficient self-assembly of cells in a three-dimensional space and allows precise control over cell types, quantities, and spatial distri

  • Our NAC-Organ technology allows for the preparation of a 3D liver model (NAC-Liver) containing hepatocytes and non-parenchymal cells within 24 hours. NAC-Liver can be stably cultured in vitro for over 30 days, maintaining high levels of hepatocyte secreti

  • The automated cultivation system developed for NAC-organ enables high-throughput automated cultivation and testing of 3D models, ensuring standardization of the models and reproducibility of the test results. By utilizing high-content imaging systems, hig

Industry News

News Center

03-01
2024

学术 | 肿瘤类器官,医学科技的崭新篇章

肿瘤类器官为更准确的癌症研究带来新希望。

02-02
2024

朴衡博迈完成新一轮融资

朴衡博迈(上海)生物医药有限公司(以下简称“朴衡博迈”,原苏...

12-18
2023

看得见的浸润 | 朴衡科技助力鲲石生物发布C...

近日,『朴衡科技』与『鲲石生物』的战略合作成果在生命科学预印...

11-27
2023

免疫炎症新药发现-靶点与技术研讨成功举办!

1月10日,由凯斯艾生物主办的“免疫炎症新药发现-靶点与技术”主题...

10-18
2023

再生治疗突破性进展 | 人-猪异种嵌合肾脏

器官移植在治疗终末期疾病中发挥着重要作用,但供体匮乏和免疫排...

05-02
2023

朴衡科技与鲲石生物达成合作:基于体外3D实...

朴衡科技与鲲石生物达成合作:基于体外3D实体瘤模型的CAR-M...

05-01
2023

专访朴衡科技:国内首家挑战NASH的类器...

过去十年中,类器官的发展被视为干细胞研究中最令人振奋的进展之...

05-09
2023

NAC-Organ助力新靶点发现 | TrkB有望...

肝纤维化是慢性肝病发展、恶化的关键中间环节,是以肝内肌成纤维...